RybojadMLeblancTFlageulB. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol1993; 128:418–422.
2.
SchoenHFoedingerDDerflerK. Immunoapheresis in paraneoplastic pemphigus. Arch Dermatol1998; 134:706–710.
3.
AnhaltGJKimSCStanleyJR. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med1990; 323:1729–1735.
4.
HornTDAnhaltGJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol1992; 128:1091–1095.
5.
LiuAYValenzuelaRHelmTN. Indirect immunofluorescence on rat bladder transitional epithelium: A test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol1993; 28:696–699.
6.
KanwarAJDharSKaurS. Further experience with pemphigus in children. Pediatr Dermatol1994; 11:107–111.
7.
LydeCBCoxSECruzPD. Pemphigus erythematosus in a five-year-old child. J Am Acad Dermatol1994; 31:906–909.
OranjeAPvan JoostT. Pemphigoid in children. Pediatr Dermatol1989; 4:267–274.
10.
TseYLimHW. Chronic bullous dermatosis of childhood: Differentiation from other autoimmune blistering diseases in children. Int J Dermatol1994; 33:507–509.
11.
GodfreyKWojnarowskaFLeonardJ. Linear IgA disease of adults: Association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol1990; 123:447–452.
12.
WojnarowskaFMarsdenRBhogalB. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults, a comparative study demonstrating clinical and immunopathological overlap. J Am Acad Dermatol1988; 19:792–805.
13.
NaganoTTaniMAdachiA. Childhood bullous pemphigoid: Immunohistochemical, immunoelectron-microscopic, and Western blot analysis. J Am Acad Dematol1994; 30:884–888.
14.
FineJDResnickSD. Vesiculobullous and neonatal diseases. In: SchachnerLAHansenRC, eds. Pediatric dermatology. 2nd Ed. New York: Churchill Livingstone, 1995:767–809.
15.
ChernoskyMEDerbesVJBurksJW. Lichen sclerosus et atrophicus in children. Arch Dermatol1957; 75:647–652.
DuboisELTuffanelliDL. Clinical manifestations of systemic lupus erythematosus. JAMA1964; 190:104–111.
20.
KassanSSMossMLReddickRL. Progressive hilar and mediastinal lymphadenopathy in systemic lupus erythematosus on corticosteroid therapy. N Engl J Med1976; 294:1382–1383.
21.
BoulwareDWHedgpethMT. Lupus pneumonitis and anti-SSA (Ro) antibodies. J Rheumatol1989; 16:479–481.
22.
TuffanelliDLDuboisEL. Cutaneous manifestations of systemic lupus erythematosus. Arch Dermatol1964; 90:377–386.
23.
KettlerAHBeanSFDuffyJO. Systemic bullous erythematosus presenting as a bullous eruption in a child. Arch Dermatol1988; 124:1083–1087.
24.
HallRPLawleyTJSmithHR. Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy. Ann Intern Med1982; 97:165–170.
25.
JacobyRAAbrahamAA. Bullous dermatosis and systemic lupus erythematosus in a 15-year-old boy. Arch Dermatol1979; 115:1094–1097.
26.
CamisaCSharmaHM. Vesicobullous systemic lupus erythematosus. J Am Acad Dermatol1983; 9:924–933.
GammonWRBriggamanRA. Bullous SLE: A phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol1993; 100:285–335.
29.
PenneysNSWileyHEIII. Herpetiform blisters in systemic lupus erythematosus. Arch Dermatol1979; 115:1427–1428.
30.
GammonWRHeiseERBurkeWA. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: Evidence that expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol1988; 91:228–232.
